| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Cumulative meta-analysis of therapeutic trials for myocardial infarction.
|
N Engl J Med
|
1992
|
17.33
|
|
2
|
Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.
|
N Engl J Med
|
1994
|
8.80
|
|
3
|
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy.
|
Circulation
|
2000
|
5.15
|
|
4
|
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).
|
J Am Coll Cardiol
|
2001
|
4.89
|
|
5
|
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.
|
Circulation
|
2001
|
4.24
|
|
6
|
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
|
J Am Coll Cardiol
|
1999
|
4.15
|
|
7
|
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.
|
J Am Coll Cardiol
|
2001
|
3.65
|
|
8
|
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
|
J Am Coll Cardiol
|
2000
|
3.54
|
|
9
|
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology.
|
Circulation
|
2001
|
3.13
|
|
10
|
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina).
|
Circulation
|
2000
|
3.02
|
|
11
|
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
|
J Am Coll Cardiol
|
1996
|
2.81
|
|
12
|
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.
|
Lancet
|
2001
|
2.78
|
|
13
|
1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
|
Circulation
|
1999
|
2.58
|
|
14
|
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
|
Circulation
|
1990
|
2.51
|
|
15
|
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II.
|
Eur Heart J
|
2001
|
2.28
|
|
16
|
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group.
|
Ann Emerg Med
|
1997
|
2.27
|
|
17
|
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.
|
Ann Intern Med
|
1980
|
2.19
|
|
18
|
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
|
Ann Intern Med
|
1980
|
2.08
|
|
19
|
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3.
|
JAMA
|
2001
|
2.07
|
|
20
|
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.
|
J Am Coll Cardiol
|
1998
|
1.96
|
|
21
|
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS.
|
Eur Heart J
|
2002
|
1.73
|
|
22
|
Analysis of possible triggers of acute myocardial infarction (the MILIS study).
|
Am J Cardiol
|
1990
|
1.68
|
|
23
|
Bolus fibrinolytic therapy in acute myocardial infarction.
|
JAMA
|
2001
|
1.67
|
|
24
|
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size.
|
Am Heart J
|
1989
|
1.62
|
|
25
|
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy.
|
Clin Chem
|
2000
|
1.58
|
|
26
|
Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation of Infarct Size. Thrombolysis in Myocardial Infarction.
|
Am Heart J
|
1999
|
1.58
|
|
27
|
An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: executive summary of a National Heart Attack Alert Program Working Group Report.
|
Ann Emerg Med
|
1997
|
1.50
|
|
28
|
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience).
|
Am J Cardiol
|
2001
|
1.49
|
|
29
|
Equivalence trials.
|
N Engl J Med
|
1997
|
1.48
|
|
30
|
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction.
|
Eur Heart J
|
2001
|
1.47
|
|
31
|
Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials.
|
Circulation
|
1991
|
1.42
|
|
32
|
Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.
|
Am Heart J
|
1995
|
1.42
|
|
33
|
ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).
|
Circulation
|
1996
|
1.42
|
|
34
|
Digitalis glycosides: mechanisms and manifestations of toxicity. Part I.
|
Prog Cardiovasc Dis
|
1984
|
1.41
|
|
35
|
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy.
|
Circulation
|
2001
|
1.34
|
|
36
|
External noninvasive temporary cardiac pacing: clinical trials.
|
Circulation
|
1985
|
1.26
|
|
37
|
Atherosclerotic aneurysms of aortocoronary vein grafts.
|
Am J Cardiol
|
1988
|
1.21
|
|
38
|
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B.
|
Circulation
|
1998
|
1.19
|
|
39
|
Nonlinear dynamics in sudden cardiac death syndrome: heartrate oscillations and bifurcations.
|
Experientia
|
1988
|
1.13
|
|
40
|
Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent.
|
Circulation
|
1990
|
1.12
|
|
41
|
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.
|
Circulation
|
2000
|
1.11
|
|
42
|
Uncertainty of the time of first significance in random effects cumulative meta-analysis.
|
Control Clin Trials
|
1996
|
1.11
|
|
43
|
Low-molecular-weight heparins: an intriguing new twist with profound implications.
|
Circulation
|
1998
|
1.10
|
|
44
|
Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.
|
Circulation
|
1983
|
1.07
|
|
45
|
Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.
|
J Am Coll Cardiol
|
1999
|
1.07
|
|
46
|
Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome.
|
Am Heart J
|
1988
|
1.05
|
|
47
|
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators.
|
Am J Cardiol
|
2000
|
1.05
|
|
48
|
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction.
|
J Am Coll Cardiol
|
1999
|
1.03
|
|
49
|
Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery.
|
Circulation
|
1984
|
1.01
|
|
50
|
Digitalis glycosides: mechanisms and manifestations of toxicity. Part III.
|
Prog Cardiovasc Dis
|
1984
|
1.01
|
|
51
|
Digitalis glycosides: mechanisms and manifestations of toxicity. Part II.
|
Prog Cardiovasc Dis
|
1984
|
1.00
|
|
52
|
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.
|
J Am Coll Cardiol
|
2000
|
0.98
|
|
53
|
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy.
|
J Am Coll Cardiol
|
2000
|
0.98
|
|
54
|
Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.
|
Ann Intern Med
|
1997
|
0.97
|
|
55
|
Angioplasty guidewire velocity: a new simple method to calculate absolute coronary blood velocity and flow.
|
Am J Cardiol
|
1997
|
0.97
|
|
56
|
In vivo electrophysiological effects of lidocaine in canine acute myocardial infarction.
|
Circ Res
|
1975
|
0.95
|
|
57
|
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
|
Am J Cardiol
|
1993
|
0.95
|
|
58
|
Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
|
J Am Coll Cardiol
|
1983
|
0.93
|
|
59
|
Low-pressure cardiac tamponade.
|
Ann Intern Med
|
1979
|
0.93
|
|
60
|
The length of the hospital stay after myocardial infarction.
|
N Engl J Med
|
2000
|
0.92
|
|
61
|
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
|
Circulation
|
1988
|
0.91
|
|
62
|
Advantages and limitations of metaanalytic regressions of clinical trials data.
|
Online J Curr Clin Trials
|
1994
|
0.91
|
|
63
|
Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset.
|
Am J Med
|
1986
|
0.91
|
|
64
|
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B.
|
J Am Coll Cardiol
|
1999
|
0.91
|
|
65
|
Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy.
|
Circulation
|
1979
|
0.91
|
|
66
|
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.
|
J Interv Cardiol
|
1995
|
0.90
|
|
67
|
Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality.
|
Am Heart J
|
1992
|
0.89
|
|
68
|
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage.
|
Am Heart J
|
2001
|
0.89
|
|
69
|
Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis.
|
Am J Cardiol
|
1998
|
0.88
|
|
70
|
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia.
|
Am J Cardiol
|
1998
|
0.88
|
|
71
|
Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials).
|
Am J Cardiol
|
2000
|
0.88
|
|
72
|
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II.
|
Am J Cardiol
|
2000
|
0.87
|
|
73
|
Efficacy of intravenous propafenone for the acute management of atrial fibrillation.
|
Am J Cardiol
|
1989
|
0.86
|
|
74
|
Intravenous nitroglycerin. A review of pharmacology, indications, therapeutic effects and complications.
|
Chest
|
1981
|
0.86
|
|
75
|
Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
|
Am Heart J
|
2001
|
0.85
|
|
76
|
A second look at bivalirudin.
|
Am Heart J
|
2001
|
0.85
|
|
77
|
Magnesium in acute myocardial infarction: still an open question.
|
Can J Cardiol
|
1998
|
0.84
|
|
78
|
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.
|
J Am Coll Cardiol
|
1999
|
0.83
|
|
79
|
The role of magnesium therapy in acute myocardial infarction.
|
Clin Cardiol
|
1996
|
0.83
|
|
80
|
Blood oxygen measurements in the assessment of intracardiac left to right shunts: a critical appraisal of methodology.
|
Am J Cardiol
|
1980
|
0.83
|
|
81
|
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
|
Circulation
|
1993
|
0.83
|
|
82
|
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group.
|
Am Heart J
|
1999
|
0.83
|
|
83
|
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
|
Am J Cardiol
|
1985
|
0.81
|
|
84
|
Evidence-based coronary care.
|
Ann Intern Med
|
1997
|
0.81
|
|
85
|
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
|
Am Heart J
|
1997
|
0.81
|
|
86
|
Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story.
|
Am J Cardiol
|
1995
|
0.81
|
|
87
|
Somatized psychiatric disorder presenting as palpitations.
|
Arch Intern Med
|
1996
|
0.81
|
|
88
|
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
|
Circulation
|
1985
|
0.80
|
|
89
|
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial.
|
Am Heart J
|
2001
|
0.80
|
|
90
|
Hypotension and sinus arrest with exercise-induced hyperkalemia and combined verapamil/propranolol therapy.
|
Am J Med
|
1986
|
0.80
|
|
91
|
Pacemaker backup-mode reversion and injury during cardiac surgery.
|
Ann Thorac Surg
|
1986
|
0.80
|
|
92
|
Magnesium in acute MI. Timing is critical.
|
Circulation
|
1995
|
0.80
|
|
93
|
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.
|
Circulation
|
2000
|
0.79
|
|
94
|
Digitalis toxicity.
|
Annu Rev Med
|
1985
|
0.79
|
|
95
|
Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
|
J Am Coll Cardiol
|
1987
|
0.79
|
|
96
|
Transtelephonic electrocardiographic transmission for management of cardiac arrhythmias.
|
Am J Cardiol
|
1986
|
0.78
|
|
97
|
New heparin dosing recommendations for patients with acute coronary syndromes.
|
Am J Med
|
2001
|
0.78
|
|
98
|
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy.
|
Clin Chim Acta
|
2000
|
0.78
|
|
99
|
Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
|
Am Heart J
|
2001
|
0.78
|
|
100
|
Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram.
|
Am Heart J
|
2000
|
0.78
|
|
101
|
Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion.
|
Am Heart J
|
1987
|
0.78
|
|
102
|
The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease.
|
Clin Cardiol
|
1999
|
0.77
|
|
103
|
Antiarrhythmic drug therapy in the management of atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
1997
|
0.77
|
|
104
|
Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.
|
Coron Artery Dis
|
1999
|
0.77
|
|
105
|
Troponin measurements in ischemic heart disease: more than just a black and white picture.
|
J Am Coll Cardiol
|
2001
|
0.77
|
|
106
|
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
|
J Am Coll Cardiol
|
1988
|
0.76
|
|
107
|
Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease.
|
Am J Cardiol
|
1985
|
0.76
|
|
108
|
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy.
|
Am Heart J
|
2001
|
0.76
|
|
109
|
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy.
|
Am J Cardiol
|
2001
|
0.76
|
|
110
|
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group.
|
Am J Cardiol
|
2001
|
0.76
|
|
111
|
Diagnostic performance of cardiac troponin I in suspected acute myocardial infarction: implications for clinicians.
|
Am Heart J
|
1999
|
0.76
|
|
112
|
Low-molecular-weight heparins in the treatment of acute coronary syndromes.
|
Arch Intern Med
|
2001
|
0.75
|
|
113
|
Caeteris paribus - all things being equal.
|
Eur Heart J
|
2001
|
0.75
|
|
114
|
'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes.
|
Eur Heart J
|
2002
|
0.75
|
|
115
|
Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups.
|
J Thromb Thrombolysis
|
2001
|
0.75
|
|
116
|
Cardiac marker elevation after cardioversion: sorting out chicken and egg.
|
Eur Heart J
|
2000
|
0.75
|
|
117
|
T-type calcium channel blockade in the management of chronic ischemic heart disease.
|
Cardiovasc Drugs Ther
|
2000
|
0.75
|
|
118
|
Another chapter of the antithrombin story has been written...
|
Eur Heart J
|
1997
|
0.75
|
|
119
|
Pacemaker malfunction after nitrous oxide anesthesia.
|
Am J Cardiol
|
1985
|
0.75
|
|
120
|
Pacemaker-mediated tachycardia initiated by coincident P-wave undersensing and ventricular blanking period.
|
Pacing Clin Electrophysiol
|
1985
|
0.75
|
|
121
|
A neural network system for detection of atrial fibrillation in ambulatory electrocardiograms.
|
J Cardiovasc Electrophysiol
|
1994
|
0.75
|
|
122
|
Drug interactions with cardiac glycosides: evaluation of a possible digoxin-ethmozine pharmacokinetic interaction.
|
J Cardiovasc Pharmacol
|
1987
|
0.75
|
|
123
|
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.
|
Am J Cardiol
|
2000
|
0.75
|
|
124
|
Magnesium use in the treatment of acute myocardial infarction in the United States (observations from the Second National Registry of Myocardial Infarction).
|
Am J Cardiol
|
2001
|
0.75
|
|
125
|
Trials and tribulations of thrombin inhibition.
|
Eur Heart J
|
1996
|
0.75
|
|
126
|
Electrocardiogram by Einthoven 63 years earlier.
|
Am J Cardiol
|
1984
|
0.75
|
|
127
|
Sinus arrest and hypotension with combined amiodarone-diltiazem therapy.
|
Am Heart J
|
1985
|
0.75
|
|
128
|
Comparison of nifedipine and isosorbide dinitrate when added to maximal propranolol therapy in stable angina pectoris.
|
Am J Cardiol
|
1987
|
0.75
|
|
129
|
Magnesium in acute myocardial infarction: scientific, statistical, and economic rationale for its use.
|
Cardiovasc Drugs Ther
|
1996
|
0.75
|
|
130
|
Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery.
|
Am Heart J
|
1996
|
0.75
|
|
131
|
Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group.
|
Int J Cardiol
|
1989
|
0.75
|
|
132
|
The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent.
|
Eur J Nucl Med
|
1986
|
0.75
|
|
133
|
Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
1987
|
0.75
|
|
134
|
Demonstration of the mechanism by which mitral regurgitation mimics aortic stenosis.
|
Am J Cardiol
|
1978
|
0.75
|
|
135
|
Case studies: Simultaneous intermittent intraatrial and intraventricular conduction defects mimicking trifascicular conduction delay.
|
J Electrocardiol
|
1977
|
0.75
|
|
136
|
Respiratory difficulty after use of disopyramide.
|
N Engl J Med
|
1980
|
0.75
|
|
137
|
Nifedipine in the treatment of cardiovascular disease.
|
Pharmacotherapy
|
1986
|
0.75
|
|
138
|
Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris.
|
Eur Heart J
|
1988
|
0.75
|
|
139
|
Treatment options in unstable angina: a clinical update.
|
Eur Heart J
|
1998
|
0.75
|
|
140
|
Correction of intraoperative diastolic myocardial dysfunction with nifedipine.
|
Clin Cardiol
|
1983
|
0.75
|
|
141
|
Nifedipine therapy for coronary vasospasm.
|
Arch Mal Coeur Vaiss
|
1983
|
0.75
|
|
142
|
[Magnesium in the treatment of acute myocardial infarction. Review and controversies].
|
Arch Cardiol Mex
|
2002
|
0.75
|
|
143
|
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction.
|
Am J Cardiol
|
2000
|
0.75
|
|
144
|
Pathogenesis and pathology of coronary heart disease syndromes.
|
J Thromb Thrombolysis
|
1999
|
0.75
|
|
145
|
Superiority of enoxaparin versus unfractionated heparin for unstable angina/non-Q-wave myocardial infarction regardless of activated partial thromboplastin time.
|
Am Heart J
|
2000
|
0.75
|
|
146
|
Documented symptomatic bradycardia and symptom relief in patients receiving permanent pacemakers: an evaluation of the joint ACC/AHA pacing guidelines.
|
Pacing Clin Electrophysiol
|
1988
|
0.75
|
|
147
|
Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome.
|
Am J Cardiol
|
1993
|
0.75
|
|
148
|
Asymptomatic hyperparathyroidism.
|
JAMA
|
1977
|
0.75
|
|
149
|
Calcium channel blockers. New treatment for cardiovascular disease.
|
Am J Nurs
|
1983
|
0.75
|
|
150
|
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction.
|
Am J Cardiol
|
2001
|
0.75
|
|
151
|
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction.
|
Catheter Cardiovasc Interv
|
2001
|
0.75
|